Halozyme Therapeutics Inc HALO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
40.85quote price arrow down-0.06 (-0.15%)
Volume
46,173
Close
40.91quote price arrow up+0.50 (+1.24%)
Volume
2,054,994
52 week range
12.71 - 56.40

...

Loading . . .

KEY STATS

  • Open40.68
  • Day High41.03
  • Day Low38.81
  • Prev Close40.41
  • 52 Week High56.40
  • 52 Week High Date02/24/21
  • 52 Week Low12.71
  • 52 Week Low Date03/18/20
  • Market Cap5.534B
  • Shares Out135.28M
  • 10 Day Average Volume2.86M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • 1 Year % Change109.9

RATIOS/PROFITABILITY

  • EPS (TTM)0.90
  • P/E (TTM)45.53
  • Fwd P/E (NTM)25.21
  • EBITDA (MRQ)147.539M
  • ROE (MRQ)106.33%
  • Revenue (MRQ)267.59M
  • Gross Margin (MRQ)83.79%
  • Net Margin (MRQ)48.24%
  • Debt To Equity (MRQ)262.98%

EVENTS

  • Earnings Date05/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Halozyme Therapeutics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing oncology therapies. The Company operates in research, development and commercialization of human enzymes and other drug candidates. The Company's segment also includes research and development activities and product sales of Hylenex recombinant. The Company's development pipeline consists of clinical-stage product candidates in oncology. Its lead oncology program is PEGPH20...
Connie Matsui
Chairman
Helen Torley
President
Elaine Sun
Chief Financial Officer
Address
11388 Sorrento Valley Rd
San Diego, CA
92121-1345
United States